Filtered By:
Cancer: Lymphoma
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 33102 results found since Jan 2013.
Continuing Medical Education (CME) questions: MYC/BCL2 coexpression in diffuse large B-cell lymphoma
Source: Blood - May 16, 2013 Category: Hematology Tags: CME article Continuing Medical Education (CME) Questions Source Type: research
Primary cutaneous B-cell lymphomas: Part II. Therapy and future directions
The choice of therapy for primary cutaneous B-cell lymphoma (PCBCL) relies on correct histopathologic classification and the exclusion of systemic disease. In part II of this continuing medical education article, we will review the available therapies for the different types of PCBCL. Primary cutaneous follicle center lymphoma (PCFCL) and primary cutaneous marginal zone lymphoma (PCMZL) are indolent tumors with an excellent prognosis. They are managed similarly with local therapy, such as radiotherapy or surgical excision, for isolated disease and observation for asymptomatic multifocal presentations. Relapses are common i...
Source: Journal of the American Academy of Dermatology - August 22, 2013 Category: Dermatology Authors: Andrea Luísa Suárez, Christiane Querfeld, Steven Horwitz, Melissa Pulitzer, Alison Moskowitz, Patricia L. Myskowski Tags: Continuing Medical Education Source Type: research
Racial and ethnic health disparities in dermatology in the United States. Part 2: Disease-specific epidemiology, characteristics, management, and outcomes
Racial and ethnic disparities in dermatology negatively affect outcomes such as mortality and quality of life. Dermatologists and dermatologic surgeons should be familiar with disease-specific inequities that may influence their practice. The second article in this 2-part continuing medical education series highlights gaps in frequency, clinical presentation, management, and outcomes by race and ethnicity. We review cutaneous malignancies including basal cell carcinoma, squamous cell carcinoma, melanoma, Merkel cell carcinoma, dermatofibrosarcoma protuberans, and cutaneous T-cell lymphoma, and inflammatory disorders includ...
Source: Journal of the American Academy of Dermatology - February 6, 2022 Category: Dermatology Authors: Kimberly Shao, Jette Hooper, Hao Feng Tags: Continuing medical education Source Type: research
Clinical Learning, Didactic Education, and Research Experiences of Radiation Oncology Resident Physicians in Canada
AbstractChanges in the field of radiation oncology (RO) impacts residency training. Assessing trainee experiences is essential to inform curriculum development. We aim to explore gaps and strengths in current Canadian RO training, as we move towards competency-based medical education (CBME). An online survey was distributed to residents at all Canadian RO training programs. Surveys consisted of 66 open-ended, Likert-scale, matrix-style, and multiple-choice questions, and assessed clinical exposure, didactic teaching, professional relationships, and research experiences. Statistics were calculated from anonymized, aggregate...
Source: Journal of Cancer Education - July 3, 2020 Category: Cancer & Oncology Source Type: research
Assessing Hematologist's Knowledge of the Use of Ibrutinib and Acalabrutinib in B-Cell Malignancies
Conclusions: This activity indicates there are significant gaps in knowledge and confidence as well as barriers impeding hem/onc ability to incorporate BTK inhibitors into the treatment plans for their patients with B-cell malignancies. There is sub-optimal awareness of differences between first and second generation BTK inhibitors as well as trial data for second generation BTK inhibitors. Additional education is needed to improve the knowledge and confidence of academic and community hem/onc specialists who care for patients with CLL and MCL so they are better equipped to utilize BTK inhibitors.DisclosuresFurman: Acerta:...
Source: Blood - November 21, 2018 Category: Hematology Authors: Willis, L., Tanzola, M., Furman, R. R. Tags: 902. Health Services Research-Malignant Diseases Source Type: research
Evaluating Hematologist's Knowledge of CAR T-Cell Therapy in Hematologic Malignancies
Conclusions: This activity found knowledge and competence deficits for hem/onc practitioners related to using CAR T-cell therapy for the treatment of patients with hematologic malignancies. Additionally, the activity demonstrated large gaps in confidence discussing CAR T-cell therapy with patients/families and managing adverse events. There is sub-optimal awareness of CAR T-cell foundational knowledge, clinical trial data, and recognition of common therapy related adverse events and management strategies. Additional education is needed to improve the knowledge, competence, and confidence of academic and community hem/onc s...
Source: Blood - November 21, 2018 Category: Hematology Authors: Willis, L., Fagerlie, S. R., Neelapu, S. S. Tags: 902. Health Services Research-Malignant Diseases: Poster I Source Type: research
A call to action; national survey of teaching radiology curriculum to medical students
CONCLUSION: Radiologists are increasing their educational representation in medical school curricula. Despite this, radiology continues to be under-represented with students desiring more exposure to medical imaging. Integrating the student's perceptions with existing curricula suggests that efforts should focus on increasing awareness of which studies are appropriate and teaching students how to systematically interpret an image.PMID:36325497 | PMC:PMC9610045 | DOI:10.25259/JCIS_36_2022
Source: Clinical Lymphoma and Myeloma - November 3, 2022 Category: Cancer & Oncology Authors: Scott Andrew Rohren Serageldin Kamel Zoha A Khan Parth Patel Sammar Ghannam Akilan Gopal Peggy H Hsieh Khaled M Elsayes Source Type: research
Addressing Challenges in Living with AML: Impact of Video-Based Patient Education on Knowledge and Behavior
Conclusions: Education on AML specifically catered to patients and their families can yield immediate and sustained gains in knowledge and behavior, which may improve their adherence to treatment, quality of life, and patient outcomes.DisclosuresNo relevant conflicts of interest to declare.
Source: Blood - November 21, 2018 Category: Hematology Authors: Roc, A. C., Steensma, D. P., Rajotte, M., Turell, W. Tags: 904. Outcomes Research-Malignant Conditions: Poster III Source Type: research
Human Herpesviruses 6, 7 and 8 in Solid Organ Transplant Recipients
Human herpesviruses (HHV) 6 and 7 are ubiquitous infections that reactivate commonly in transplant recipients. However, clinical diseases due to these viruses are reported only in 1% of solid organ transplant recipients. Fever, rash and bone marrow suppression are the most common manifestations, but symptoms of tissue invasive disease may be observed. Treatment of HHV‐6 and HHV‐7 disease includes antiviral therapy and cautious reduction in immunosuppression. HHV‐8 is an oncogenic gamma‐herpesvirus that causes Kaposi's sarcoma, Castleman's disease and primary effusion lymphomas in transplant recipients. Nonmalignant...
Source: American Journal of Transplantation - January 24, 2013 Category: Transplant Surgery Authors: R. R. Razonable Tags: Continuing Medical Education Source Type: research
Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management
Disease OverviewWaldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include anemia, thrombocytopenia, hepatosplenomegaly, and lymphadenopathy.
DiagnosisThe presence of IgM monoclonal protein associated with ≥10% clonal lymphoplasmacytic cells in bone marrow confirms the diagnosis.
Risk StratificationAge, hemoglobin level, platelet count, β2 microglobulin, and monoclonal IgM concentrations are characteristics required for prognosis.
Risk‐Adapted TherapyNot all patients who fulfill WM criteria require therapy; these patients can be observe...
Source: American Journal of Hematology - June 20, 2013 Category: Hematology Authors: Morie A. Gertz Tags: Annual Clinical Updates in Hematological Malignancies: A Continuing Medical Education Series Source Type: research
Primary cutaneous B-cell lymphomas: Part I. Clinical features, diagnosis, and classification
This article will summarize the clinical, pathologic, and diagnostic features of the 3 main types of PCBCL: primary cutaneous follicle center lymphoma, primary cutaneous marginal zone lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg-type, and the appropriate evaluation and staging procedures for each of these entities.
Source: Journal of the American Academy of Dermatology - August 22, 2013 Category: Dermatology Authors: Andrea Luísa Suárez, Melissa Pulitzer, Steven Horwitz, Alison Moskowitz, Christiane Querfeld, Patricia L. Myskowski Tags: Continuing Medical Education Source Type: research
The aggressive peripheral T‐cell lymphomas: 2013
BackgroundT‐cell lymphomas make up approximately 10–15% of lymphoid malignancies. The frequency of these lymphomas varies geographically, with the highest incidence in parts of Asia.
DiagnosisThe diagnosis of aggressive peripheral T‐cell lymphoma (PTCL) is usually made using the WHO classification. The ability of hematopathologists to reproducibly diagnosis aggressive PTCL is lower than for aggressive B‐cell lymphomas, with a range of 72–97% for the aggressive PTCLs.
Risk StratificationPatients with aggressive PTCL are staged using the Ann Arbor Classification. Although somewhat controversial, PET scans appear to...
Source: American Journal of Hematology - September 19, 2013 Category: Hematology Authors: James O. Armitage Tags: Annual Clinical Updates in Hematological Malignancies: A Continuing Medical Education Series Source Type: research
Mantle cell lymphoma: 2013 Update on diagnosis, risk‐stratification, and clinical management
Disease OverviewMantle cell lymphoma (MCL) is a non‐Hodgkin lymphoma characterized by involvement of the lymph nodes, spleen, blood, and bone marrow with a short remission duration to standard therapies and a median overall survival of 4–5 years.
DiagnosisDiagnosis is based on lymph node, bone marrow, or tissue morphology of centrocytic lymphocytes, small cell type, or blastoid variant cells. A chromosomal translocation t(11:14) is the molecular hallmark of MCL, resulting in the overexpression of cyclin D1. Cyclin D1 is detected by immunohistochemistry in 98% of cases. The absence of SOX‐11 or a low Ki‐67 may corre...
Source: American Journal of Hematology - November 22, 2013 Category: Hematology Authors: Julie M. Vose Tags: Annual Clinical Updates in Hematological Malignancies: A Continuing Medical Education Series Source Type: research
